Empresa Benitec Biopharma Limited Deutsche Boerse AG
Acciones
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 01/10/16 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/15 |
Megan Boston
CMP | Compliance Officer | 52 | 01/08/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 01/04/13 |
Edward Smith
BRD | Director/Board Member | 53 | 14/04/20 |
Peter Francis
BRD | Director/Board Member | 68 | 01/02/06 |
Jerel Banks
CEO | Chief Executive Officer | 49 | 01/10/16 |
Megan Boston
CMP | Compliance Officer | 52 | 01/08/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 9 367 485 | 8 497 929 ( 90,72 %) | 0 | 90,72 % |
Información de la empresa
![Dirección Benitec Biopharma Limited](https://cdn.zonebourse.com/static/address/453260.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 47,96 mil M | |
+45,66 % | 41,47 mil M | |
+0,69 % | 42,45 mil M | |
+30,52 % | 31,6 mil M | |
+22,30 % | 28,63 mil M | |
-6,35 % | 28,03 mil M | |
+49,25 % | 14,56 mil M | |
+49,18 % | 14,14 mil M | |
+3,45 % | 12,58 mil M |